Bidding for Pliva

Pliva d.d. shares soared to the highest level in more than eight years after the Financial Times said Barr Pharmaceuticals Inc. may have offered $2.1 billion for eastern Europe's largest drugmaker.
...
Pliva Chief Executive Officer Zeljko Covic is in talks with several companies and has said he will present investors with a list of potential buyers in coming months. He started talking to other pharmaceutical companies after receiving an unsolicited bid from Icelandic generic-drug maker Actavis hf in March.
...
Generic versions of biologically engineered drugs, which are altered forms of proteins and other naturally occurring substances from the human body, loom as a potentially key profit driver for generic drug companies.
...
European regulators are seen as moving faster than their U.S. counterparts in paving the way to develop generic versions of such biologic medicines, which generally are more complicated to duplicate than traditional, chemically derived pharmaceuticals.

1 2 3

BBC Interview

Guy Goma, a graduate from the Congo, appeared on the news channel in place of an IT expert after a mix-up.

But Mr Goma, who was wrongly identified in the press as a taxi driver, was really at the BBC for a job interview.

Mr Goma said his appearance was "very stressful" and wondered why the questions were not related to the data support cleanser job he applied for.

The mix-up occurred when a producer went to collect the expert from the wrong reception in BBC Television Centre in West London.


1

Windows Live Academic

Microsoft has debuted its answer to the literature search engine Google Scholar Released last month as a beta version, Windows Live Academic ferrets out articles and abstracts from more than 6000 journals and conferences. So far, the site only covers electrical engineering, computer science, and physics, but Microsoft plans to add more disciplines. Unlike Google Scholar, Windows Live Academic doesn't factor the number of citations into its rankings of articles, relying instead on each paper's quality and how closely it matches your search criteria. Microsoft's engine also offers more options for displaying the results, which you can sort by date, journal, author, or conference. But you'll still need subscriptions to access many of the articles.

link
1